Live·Verified funding discovery · 2026.2
882 grants · 20 open · 435 companies · 2640 concepts882 / 20 / 435 / 2640
⧗GRANTDocumentary Production · Screen Australia closes 24 SEPT⧗GRANTInstitutional Development Award (IDeA) for Clinical & Translational Research · National Institute of General Medical Sciences (NIGMS), National Institutes of Health closes 25 SEPT△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE882 grants in catalogue · 20 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA⧗GRANTDocumentary Production · Screen Australia closes 24 SEPT⧗GRANTInstitutional Development Award (IDeA) for Clinical & Translational Research · National Institute of General Medical Sciences (NIGMS), National Institutes of Health closes 25 SEPT△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE882 grants in catalogue · 20 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Michael Chinen

Michael Chinen

vc
Fund operator

About

Michael Chinen is a co-founder and General Partner at Healthspan Capital, an early-stage longevity biotech venture firm founded in 2021. Healthspan Capital's profile says he is a software engineer and machine learning researcher who works at Google on audio-related research, after earlier roles at Microsoft, Dolby, Adobe, and Bay Area startups. The firm also notes that his earlier work on DNA sequence alignment software at the University of Washington helped spark his interest in biology and aging.

Areas of interest

longevitybiotechregenerative medicineAImachine learningaudio technologyaging researchhealthspan extensionearly-stage venture